Shenzhen Kangtai Biological Products Co Ltd Class A 300601
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- CNY 19.72
- Day Range
- CNY 19.55–19.95
- 52-Week Range
- CNY 18.44–34.18
- Bid/Ask
- CNY 19.62 / CNY 19.63
- Market Cap
- CNY 21.91 Bil
- Volume/Avg
- 7.5 Mil / 10.8 Mil
Key Statistics
- Price/Earnings (Normalized)
- 41.24
- Price/Sales
- 7.06
- Dividend Yield (Trailing)
- 0.91%
- Dividend Yield (Forward)
- 0.91%
- Total Yield
- 0.88%
Company Profile
Shenzhen Kangtai Biological Products Co Ltd is a human vaccine research and development company. The company is engaged in the research and development, production and sales of recombinant hepatitis B vaccine, b -type influenza Haemophilus conjugate vaccine, measles-rubella combined live attenuated vaccine, cell-free baibai broke b Haemophilus influenzae vaccine and other products.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Mid Core
- Total Number of Employees
- 1,902
- Website
- http://www.biokangtai.com
Comparables
Valuation
|
Metric
|
300601
|
300142
|
300841
|
|---|---|---|---|
Price/Earnings (Normalized) | 41.24 | 45.09 | 13.87 |
Price/Book Value | 2.36 | 2.54 | 2.31 |
Price/Sales | 7.06 | 6.09 | 5.12 |
Price/Cash Flow | 27.12 | 27.66 | 12.58 |
Price/Earnings
300601
300142
300841
Financial Strength
|
Metric
|
300601
|
300142
|
300841
|
|---|---|---|---|
Quick Ratio | 1.47 | 2.46 | 4.14 |
Current Ratio | 2.15 | 2.85 | 4.49 |
Interest Coverage | 2.18 | 47.19 | 119.95 |
Quick Ratio
300601
300142
300841
Profitability
|
Metric
|
300601
|
300142
|
300841
|
|---|---|---|---|
Return on Assets (Normalized) | 3.75% | 3.37% | — |
Return on Equity (Normalized) | 5.79% | 5.57% | — |
Return on Invested Capital (Normalized) | 4.61% | 3.91% | — |
Return on Assets
300601
300142
300841
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ZTS
| Zoetis Inc Class A | Zvggkrsmb | Xkhr | $79.1 Bil | |
MKKGY
| Merck KGaA ADR | Ystdqnrzs | Nrsts | $74.3 Bil | |
HLN
| Haleon PLC ADR | Nztdpnfx | Pndhf | $38.1 Bil | |
TEVA
| Teva Pharmaceutical Industries Ltd ADR | Xjqhqnrt | Yfmm | $19.1 Bil | |
VTRS
| Viatris Inc | Sjgdmrd | Kpmt | $13.2 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Qbzzylbsm | Ytby | $11.7 Bil | |
CTLT
| Catalent Inc | Jvjqzms | Kxgxsc | $10.0 Bil | |
CURLF
| Curaleaf Holdings Inc | Rfphgvt | Cmwx | $4.2 Bil | |
PRGO
| Perrigo Co PLC | Yyhqrfr | Dsy | $4.1 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Rlyxgzlfw | Cqfbdp | $3.3 Bil |